SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549

                                    FORM 10-Q


                 QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934




For Quarter Ended            January 31, 1998
Commission File Number       0-3319

                          DEL GLOBAL TECHNOLOGIES CORP.
                          -----------------------------
             (Exact name of registrant as specified in its charter)


          New York                                        13-1784308
          --------                                        ----------
(State or other jurisdiction of                        (I.R.S. Employer
incorporation or organization)                        Identification No.)

                      One Commerce Park, Valhalla, NY 10595
                      -------------------------------------
                    (Address of principal executive offices)
                                   (Zip Code)

                                 (914) 686-3600
                                 --------------
               (Registrant's telephone number including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

Yes   X                No

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the close of the business on March 13, 1998.

                            Common Stock - 7,542,937




<PAGE>





                                     PART I


Item 1.  FINANCIAL STATEMENTS

              Consolidated Balance Sheets - January 31, 1998 and August 2, 1997

              Consolidated  Statements  of Income  for the Three  Months and Six
              Months ended January 31, 1998 and February 1, 1997

              Consolidated  Statements  of Cash Flows for the Six  Months  ended
              January 31, 1998 and February 1, 1997

              Notes to Consolidated Financial Statements


                                       -1-

<PAGE>



                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS
                                   (Unaudited)

                                     ASSETS
                                                         January 31,   August 2,
                                                            1998         1997
                                                        -----------  -----------

CURRENT ASSETS
        Cash and cash equivalents                       $ 5,377,578  $ 6,070,608
        Investments available-for-sale                      854,454      722,566
        Trade receivables - net                          12,382,438   11,211,357
        Cost and estimated earnings in excess of
             billings on uncompleted contracts            2,061,671    1,868,002
        Inventory                                        26,302,076   24,681,348
        Prepaid expenses and other current assets         2,441,640    1,808,762
                                                        -----------  -----------
             Total current assets                        49,419,857   46,362,643
                                                        -----------  -----------

FIXED ASSETS - Net                                       11,719,584   11,159,010
INTANGIBLES - Net                                         1,027,217    1,112,991
GOODWILL - Net                                            4,039,722    4,135,409
DEFERRED CHARGES                                            448,634      507,933
OTHER ASSETS                                                870,278      851,824
                                                        -----------  -----------
        TOTAL                                           $67,525,292  $64,129,810
                                                        ===========  ===========

                      LIABILITIES AND SHAREHOLDERS' EQUITY


CURRENT LIABILITIES
        Current portion of long-term debt               $   127,209  $   127,999
        Accounts payable - trade                          4,496,341    3,936,529
        Accrued liabilities                               3,535,916    3,699,188
        Deferred compensation liability                     816,707      722,566
        Income taxes                                        791,204      868,949
                                                        -----------  -----------
             Total current liabilities                    9,767,377    9,355,231
                                                        -----------  -----------

LONG-TERM LIABILITIES
        LONG-TERM DEBT (less current
             portion included above)                        345,719      411,127
        OTHER                                               744,222      725,258
        DEFERRED INCOME TAXES                             1,225,968    1,107,964
                                                        -----------  -----------
             Total liabilities                           12,083,286   11,599,580
                                                        -----------  -----------

SHAREHOLDERS' EQUITY
        Common stock, $.10 par value;
                   Authorized 20,000,000 shares;
                   Issued and outstanding -
                   7,705,163 shares at January 31,
                   1998 and 7,516,234 shares at
                   August 2, 1997                           770,516      751,622
        Additional paid-in capital                       47,101,060   45,909,517
        Retained earnings                                 9,191,786    6,572,318
                                                        -----------  -----------
                                                         57,063,362   53,233,457
                                                        -----------  -----------
        Less common stock in treasury -
                   198,155 shares at January 31, 1998
                   and 104,255 at August 2, 1997          1,621,356      703,227
                                                        -----------  -----------
                   Total shareholders' equity            55,442,006   52,530,230
                                                        -----------  -----------
        TOTAL                                           $67,525,292  $64,129,810
                                                        ===========  ===========

   See notes to consolidated financial statements


                                       -2-

<PAGE>



                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                        CONSOLIDATED STATEMENTS OF INCOME
                                   (Unaudited)


<TABLE>
<CAPTION>
                                                           Three Months Ended                     Six Months Ended
                                                    -------------------------------         ------------------------------
                                                     January 31,        February 1,         January 31,        February 1,
                                                        1998               1997                 1998              1997
                                                    -----------         -----------         -----------        -----------
<S>                                                 <C>                 <C>                 <C>                <C>        
NET SALES                                           $14,403,182         $12,691,871         $27,883,251        $25,003,255
                                                    -----------         -----------         -----------        -----------
COSTS AND EXPENSES:
     Cost of sales                                    8,503,015           7,558,599          16,550,560         15,064,837
     Research and development                         1,464,357           1,115,612           2,700,246          2,192,439
     Selling, general and 
         administrative                               2,476,438           2,434,208           4,878,837          4,759,747
     Interest income - net                               44,275              27,840              98,550             47,296
                                                    -----------         -----------         -----------        -----------
                                                     12,399,535          11,080,579          24,031,093         21,969,727
                                                    -----------         -----------         -----------        -----------
INCOME BEFORE PROVISION
FOR INCOME TAXES                                      2,003,647           1,611,292           3,852,158          3,033,528
PROVISION FOR INCOME TAXES                              641,167             491,444           1,232,691            925,226
                                                    -----------         -----------         -----------        -----------
NET INCOME                                          $ 1,362,480         $ 1,119,848         $ 2,619,467        $ 2,108,302
                                                    ===========         ===========         ===========        ===========
Per share amounts:
     Basic earnings per share                       $       .18         $       .15         $       .35        $       .28
                                                    ===========         ===========         ===========        ===========
     Diluted earnings per share                     $       .17         $       .14         $       .32        $       .26
                                                    ===========         ===========         ===========        ===========
Weighted average number of
      common shares outstanding                       7,472,140           7,399,932           7,455,775          7,407,594
                                                    ===========         ===========         ===========        ===========
Weighted average number of    
      common shares outstanding
      and common share equivalents                    8,172,285           8,071,111           8,172,142          8,082,482
                                                    ===========         ===========         ===========        ===========
</TABLE>
See notes to consolidated financial statements


                                       -3-

<PAGE>



                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS

                                   (Unaudited)

                                                          Six Months Ended
                                                      -------------------------
                                                      January 31,    February 1,
                                                         1998           1997
                                                      -----------   -----------
CASH FLOWS FROM OPERATING ACTIVITIES:
  Net Income                                          $ 2,619,467   $ 2,108,302
    Adjustments to reconcile net income
      to net cash provided by operating
      activities:
        Imputed interest                                   46,793        33,968
        Depreciation                                      657,821       471,697
        Amortization                                      264,646       263,782
        Deferred income tax provision
          (benefit)                                       114,759       (11,996)
        Tax benefit from exercise of
          stock options and warrants                      325,594       147,617
        Changes in assets and liabilities:
          Increase in trade receivables                (1,171,081)     (311,931)
          Increase in cost and estimated
            earnings in excess of billings
            on uncompleted contracts                     (193,669)         --
          Increase in inventory                        (1,620,728)   (1,676,493)
          Increase in prepaid and other
            current assets                               (652,476)     (306,878)
          Increase in other assets                        (17,259)       (4,675)
          Increase in accounts payable - trade            559,812       499,585
          Decrease in accrued liabilities                (163,272)     (466,044)
          Increase in deferred compensation
            liability                                      94,141        94,632
          (Decrease) increase in income taxes
            payable                                       (77,745)       31,301
                                                      -----------   -----------
        Net cash provided by operating activities         786,803       872,867
                                                      -----------   -----------

CASH FLOWS FROM INVESTING ACTIVITIES:
          Expenditures for fixed assets                (1,218,395)   (1,137,813)
          Investment in marketable securities            (131,888)      (94,632)
          Cash paid on acquisition of subsidiaries           --         (15,000)
          Payments to former shareholders of
            subsidiary acquired                           (27,829)      (27,850)
                                                      -----------   -----------
        Net cash used in investing activities          (1,378,112)   (1,275,295)
                                                      -----------   -----------

CASH FLOWS FROM FINANCING ACTIVITIES:
          Net (repayment of) proceeds from bank
            borrowing                                     (66,198)       29,110
          Payment for repurchase of shares               (918,129)      (73,310)
          Proceeds from exercise of stock options
            and warrants                                  841,153       175,338
          Other                                            41,453       (18,334)
                                                      -----------   -----------
        Net cash (used in) provided by financing
          activities                                     (101,721)      112,804
                                                      -----------   -----------

                                                                     (Continued)
See notes to consolidated financial statements


                                       -4-

<PAGE>









                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS

                                   (Unaudited)


                                                          Six Months Ended
                                                      -------------------------
                                                      January 31,    February 1,
                                                         1998           1997
                                                      -----------   -----------
NET DECREASE IN CASH AND CASH EQUIVALENTS             $  (693,030)  $  (289,624)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD          6,070,608     5,817,800
                                                      -----------   -----------
CASH AND CASH EQUIVALENTS, END OF PERIOD              $ 5,377,578   $ 5,528,176
                                                      ===========   ===========

SUPPLEMENTAL DISCLOSURES OF CASH FLOW
             INFORMATION:

             Interest paid                            $    62,587   $    27,950
                                                      ===========   ===========
             Income taxes paid                        $   865,083   $   747,057
                                                      ===========   ===========







See notes to consolidated financial statements




                                       -5-

<PAGE>



                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (Unaudited)
                
NOTE 1         In the  opinion of the  Company's  management,  the  accompanying
               unaudited   consolidated   financial   statements   contain   all
               adjustments  (consisting  of only normal  recurring  adjustments)
               necessary  to  present   fairly  the  results  of  the  Company's
               financial  position as of January 31, 1998 and the results of its
               operations  and its cash flows for the six months  ended  January
               31, 1998 and February 1, 1997, respectively.

               The accounting  policies followed by the Company are set forth in
               Note 1 to the  Company's  financial  statements  as of  August 2,
               1997, except as stated below.

               The Company adopted  Statement of Financial  Accounting  Standard
               No. 128 ("SFAS 128"),  "Earnings Per Share"  effective  August 3,
               1997.  The effect of the  adoption of SFAS 128 on the quarter and
               six months  ended  February  1, 1997 was to reduce  the  weighted
               average common shares and common share equivalents from 8,620,692
               to 8,071,111  and from  8,561,147 to 8,082,482  for the three and
               six month periods ended February 1, 1997,  respectively.  Diluted
               earnings  per  share  were  $.14  and $.26 as  compared  to fully
               diluted earnings per share of $.13 and $.25 for the three and six
               month periods ended February 1, 1997, respectively.

               The  consolidated   financial   statements   should  be  read  in
               conjunction  with the  notes to the  financial  statements  as of
               August 2, 1997.

NOTE 2         The  results of  operations  for the three and six month  periods
               ended  January 31,  1998 are not  necessarily  indicative  of the
               results to be expected for the full year.

NOTE 3         INVESTMENTS

               Investments  available-for-sale at January 31, 1998 and August 2,
               1997  include  $748,402  and  $722,566,   respectively,  for  the
               Company's  President's  deferred  compensation,  pursuant  to the
               terms of his employment contract. The liabilities of $816,707 and
               $722,566,  respectively,  are  recorded as deferred  compensation
               liability.   The  difference  of  $68,305   between   investments
               available-for-sale  and the deferred compensation  liability were
               cash assets at January 31,  1998 and were  classified  as such in
               the financial statements.  Gains and losses, either recognized or
               unrealized,  inure to the benefit or detriment of the President's
               deferred  compensation,  based  upon  a  contractual  arrangement
               between the President and the Company.  At January 31, 1998,  the
               balance of investments  available-for-sale of $106,052 are equity
               securities held by the Company for its own account.  Realized and
               unrealized  gains and losses on these  securities  for the period
               ended  January 31, 1998 were not material and are recorded in the
               financial statements.

NOTE 4         PERCENTAGE OF COMPLETION ACCOUNTING
                                                                        Six
                                                                       Months
                                                                       Ended    
                                             January 31,  August 2,  January 31,
                                                1998        1997        1998
                                             ----------  ----------  ----------

               Costs incurred on
                 uncompleted contracts       $3,997,181  $3,086,020  $  911,161

               Estimated earnings             2,410,522   1,578,126     832,396
                                             ----------  ----------  ----------
                                              6,407,703   4,664,146   1,743,557
               Less:  Billings to date        4,346,032   2,796,144   1,549,888
                                             ----------  ----------  ----------

               Costs and estimated
                 earnings in excess of
                 billings on uncompleted
                 contracts                   $2,061,671  $1,868,002  $  193,669
                                             ==========  ==========  ==========


                                       -6-

<PAGE>



               There were no contracts  accounted  for under the  percentage  of
               completion method of accounting for the six months ended February
               1, 1997. The backlog of unshipped  contracts  being accounted for
               under the  percentage  of  completion  method of  accounting  was
               approximately $3,128,000 at January 31, 1998.


NOTE 5         INVENTORY

               Inventory is stated at a lower of cost  (first-in,  first-out) or
               market.

               Inventories  and their effect on cost of sales are  determined by
               physical count for annual reporting purposes and are estimated by
               management for interim reporting purposes.

               Inventory consists of the following:
                                                       January 31,   August 2,
                                                           1998         1997
                                                       -----------  -----------

               Finished goods                          $ 4,113,304  $ 3,859,842
               Work-in-process                          10,412,403    9,770,789
               Raw material and purchased parts         11,776,369   11,050,717
                                                       -----------  -----------
               Total                                   $26,302,076  $24,681,348
                                                       ===========  ===========


NOTE 6         FIXED ASSETS

               Fixed assets consist of the following:
                                                       January 31,   August 2,
                                                          1998         1997
                                                       -----------  -----------

               Land                                    $   694,046  $   694,046
               Building                                  2,146,025    2,146,025
               Machinery and equipment                  11,860,424   10,865,897
               Furniture and fixtures                    1,351,134    1,280,216
               Leasehold improvements                    1,381,942    1,228,992
               Transportation equipment                     30,103       30,103
                                                       -----------  -----------
                                                        17,463,674   16,245,279

               Less accumulated depreciation
                 and amortization                        5,744,090    5,086,269
                                                       -----------  -----------

               Net fixed assets                        $11,719,584  $11,159,010
                                                       ===========  ===========


NOTE 7         SUBSEQUENT EVENT

               On  March  6,  1998  the  Company's   Gendex-Del   Imaging  Corp.
               subsidiary acquired selected assets of X-Ray  Technologies,  Inc.
               consisting principally of inventory, fixed assets and intangibles
               for  cash.  X-Ray   Technologies,   Inc.  is  a  manufacturer  of
               cost-effective    medical   imaging   systems   for   physicians,
               chiropractors and veterinarians.




                                       -7-

<PAGE>



Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
         AND RESULTS OF OPERATIONS

This  Management  Discussion and Analysis of Financial  Condition and Results of
Operations contains forward looking statements.  Such statements involve various
risks that may cause actual results to differ  materially.  These risks include,
but are not  limited to, the  ability of the  Company to grow  internally  or by
acquisition  and  to  integrate  acquired   businesses,   changing  industry  or
competitive   conditions,   and  other  risks   referred  to  in  the  Company's
registration  statements  and periodic  reports  filed with the  Securities  and
Exchange Commission.

OVERVIEW

                 The  Company's  net sales  have  increased  as a result of both
internal growth and acquisitions.  The Company has completed three  acquisitions
in the past five years:  Dynarad (a designer and manufacturer of medical imaging
systems and critical  electronic  subsystems) in fiscal 1993; Bertan (a designer
and  manufacturer  of precision high voltage power supplies and  instrumentation
for medical and  industrial  applications)  in fiscal 1994;  and  Gendex-Del  (a
manufacturer of medical imaging systems) in fiscal 1996. The Company's net sales
have increased from approximately  $18.9 million in fiscal 1992 to approximately
$54.7 million in fiscal 1997, a compounded annual growth rate of 23.6%.

                 During the past five years the Company has grown internally and
through  acquisitions into a company whose  predominant  business is serving the
medical imaging and diagnostic markets.  The Company's net sales attributable to
medical imaging products have increased from approximately $3.4 million or 17.7%
of total net sales in fiscal 1992 to approximately $25.7 million or 59% of total
net sales and approximately  $35.6 million or 65.1% of total net sales in fiscal
years 1996 and 1997, respectively.

                 Management  believes that recent cost containment trends in the
healthcare  industry have created  opportunities for its cost-effective  medical
imaging products in domestic and international markets. Some of these trends are
increased  demand for lower cost medical  equipment,  outsourcing of systems and
critical  electronic  subsystems  by leading  Original  Equipment  Manufacturers
("OEMs"),  increased  demand for certain  diagnostic  procedures  and lower cost
medical services in the global marketplace.

RESULTS OF OPERATIONS

                 Net sales for the three  months  ended  January  31,  1998 were
approximately  $14.4 million as compared to approximately  $12.7 million for the
three months ended February 1, 1997, an increase of 13.5%. Net sales for the six
months ended  January 31, 1998 were  approximately  $27.9 million as compared to
approximately  $25.0  million  for the six months  ended  February  1, 1997,  an
increase of 11.5%.  These  increases  are due to internal  growth from  existing
operations.

                 Cost of  sales,  as a  percentage  of net  sales  for the three
months  ended  January  31,  1998,  was 59%  compared  to  59.6%  for the  prior
corresponding  period.  Cost of sales,  as a percentage of net sales for the six
months  ended  January  31,  1998,  was  59.4%  compared  to 60.3% for the prior
corresponding   period.  These  improvements  in  margins  are  due  to  reduced
manufacturing costs from efficiencies implemented in existing operations.

                 Research and development  expenses  increased to  approximately
$1.5 million for the three months ended January 31, 1998 from approximately $1.1
million,  an increase of 31.3%,  for the three  months  ended  February 1, 1997.
Research and development  expenses  increased to approximately  $2.7 million for
the six months ended  January 31, 1998 from  approximately  $2.2 million for the
six months ended  February 1, 1997,  an increase of 23.2% These  increases  were
primarily  due to new product  development.  The Company  continues to invest in
research and development in order to introduce new state-of-the-art products for
its medical and industrial markets.

                                      -8-
<PAGE>

                 Selling, general and administrative expenses were approximately
$2,476,000,  or 17.2% of net sales,  for the three months ended January 31, 1998
as compared to  approximately  $2,434,000,  or 19.2% of net sales,  for the same
period  in  the  prior  year,  an  increase  of  1.7%.   Selling,   general  and
administrative expenses increased to approximately  $4,879,000,  or 17.5% of net
sales for the six months ended January 31, 1998 from  $4,759,000,  or 19% of net
sales over the  corresponding  period in the prior  year,  an  increase of 2.5%.
Theses  increases were due to higher levels of advertising  and increased  trade
show attendance.

                 Net  interest  income was  approximately  $44,000 for the three
months  ended  January 31, 1998 as  compared  to  approximately  $28,000 for the
corresponding  period in the prior year, an increase of 59%. Net interest income
was approximately  $99,000 for the six months ended January 31, 1998 as compared
to approximately  $47,000 for the six months ended February 1, 1997, an increase
of 108.4%.  Interest  income  resulted  from the  investment of a portion of the
proceeds  from the public  offering of the  Company's  common  stock,  which are
invested in money market instruments and high grade commercial paper.

                 Income  tax  expense  was 32% of  pre-tax  income for the three
months and six months ended January 31, 1998. The decrease from statutory  rates
is  primarily  due to sales  being made  through  the  Company's  Foreign  Sales
Corporation, research and development and other tax credits.

                 Net income  increased  to  approximately  $1.4  million for the
three months ended  January 31, 1998,  an increase of  approximately  21.7% from
approximately  $1.1 million for the prior  corresponding  period. Net income per
common share for the three months ended January 31, 1998  increased to $.18 from
$.15 for the three months ended February 1, 1997, an increase of 20%. Net income
per common  share and  common  share  equivalent  rose to $.17 from $.14 for the
three  months  ended  January 31, 1998 and  February 1, 1997,  respectively,  an
increase of 21.4%.  The number of common shares  outstanding at January 31, 1998
were  7,472,140  as compared  to  7,399,932  at February 1, 1997.  The number of
common  shares and common  share  equivalents  at January 31, 1998  increased to
8,172,285  from  8,071,111  at  February  1,  1997.  Net  income   increased  to
approximately  $2.6  million  for the six months  ended  January  31,  1998,  an
increase of approximately  24.2% from  approximately  $2.1 million for the prior
corresponding  period.  Net  income per  common  share for the six months  ended
January 31, 1998  increased to $.35 from $.28 for the six months ended  February
1, 1997,  an increase  of 13.6%.  Net income per common  share and common  share
equivalent  rose to $.32 from $.26 for the six months ended January 31, 1998 and
February  1, 1997,  respectively,  an  increase  of 23.1%.  The number of common
shares  outstanding  at January 31, 1998 were 7,455,775 as compared to 7,407,594
at February 1, 1997. The number of common shares and common share equivalents at
January 31, 1998  increased to 8,172,142 from 8,082,482 at February 1, 1997. The
increase  in net income for the three and six month  periods  ended  January 31,
1998 is due to internal growth and improved gross margins.

                 The  backlog  of  unshipped  orders  at  January  31,  1998 was
approximately $31.5 million.

LIQUIDITY AND CAPITAL RESOURCES

                 The Company has funded its operations and acquisitions  through
a combination of cash flow from  operations,  bank borrowing and the issuance of
the Company's common stock.

                 Working  Capital.  At January 31, 1998 and August 2, 1997,  the
Company's  working  capital was  approximately  $39.7 million and $37.0 million,
respectively.  At such dates the Company had approximately $5.4 million and $6.1
million,  respectively,  in cash and cash equivalents.  The Company  anticipates
that cash generated from operations and amounts available under its bank lending
facilities will be sufficient to satisfy its current operating cash needs.

                                       -9-

<PAGE>

                 Trade  receivables at January 31, 1998 increased  approximately
$1.2  million as compared to August 2, 1997  primarily  due to  increased  sales
levels.

                 Cost  and   estimated   earnings   in  excess  of  billings  on
uncompleted  contracts  increased to  approximately  $2.1 million at January 31,
1998 from  approximately  $1.9 million at August 2, 1997 due to additional  work
performed in the six month period on long term contracts accounted for under the
percentage of completion method of accounting.

                 Inventory  at January 31,  1998  increased  approximately  $1.6
million  as  compared  to  August  2,  1997,  primarily  because  of  additional
production  requirements  of new OEM  contracts  which  commenced  in the  third
quarter of fiscal 1997 and to support higher levels of medical  imaging  systems
sales.

                 Prepaid   expenses   and   other   current   assets   increased
approximately $632,000 at January 31, 1998 from August 2, 1997 primarily because
of higher  levels of  prepaid  insurance,  trade  show  deposits,  printing  and
catalogue costs.

                 Trade  accounts  payable  increased  approximately  $560,000 at
January  31,  1998 from  August  2,  1997  primarily  because  of the  increased
inventory  requirements  of new OEM  contracts  and to support  higher levels of
shipments of medical imaging products.

                 Credit Facility and Borrowing. At January 31, 1998, the Company
had a $14 million  revolving  credit line and a $10 million  acquisition  credit
line. The available portion of the revolving credit line was approximately $13.7
million,   after  deducting  outstanding  letters  of  credit  of  approximately
$180,000.

                 Capital  Expenditures.  The  Company  continues  to  invest  in
capital  equipment,  principally for its manufacturing  operations and inventory
management  systems,  in order to improve its  manufacturing  capability  and to
increase  capacity and inventory turns.  The Company has expended  approximately
$1.2 million for capital  equipment  for the six month period ended  January 31,
1998.

                 Shareholders'   Equity.   Shareholders'   equity  increased  to
approximately $55.4 million at January 31, 1998 from approximately $52.5 million
at August 2, 1997,  primarily  due to the results of  operations.  Additionally,
during  the  period  approximately  177,674  stock  options  and  warrants  were
exercised,  with proceeds of approximately  $841,000 and 93,900 shares of common
stock were  repurchased at a cost of approximately  $918,000.  Under its current
stock "Buy-back"  program since April, 1997 the Company has repurchased  126,900
shares of its  common  stock for  $1,201,922  at prices  ranging  from  $7.88 to
$11.13. The average repurchase price was $9.47.

Year 2000 Compliance

                 The  Company  relies  on  computer  technology  throughout  its
business to effectively carry out its day-to-day  operations.  As the millennium
approaches,  the Company is assessing all of its computer systems to ensure that
they are "Year  2000"  compliant.  In this  process  the  Company may replace or
upgrade  certain  systems which are not Year 2000 compliant in order to meet its
internal  need and those of its  customers.  The  Company  expects its Year 2000
project to be completed on a timely  basis.  However,  there can be no assurance
that the systems of other  companies  on which the Company may rely will also be
timely  converted or that such failure to convert by other  companies  would not
have an adverse effect on the Company's systems. The cost to the Company of such
changes  are  difficult  to  estimate  but are not  expected  to have a material
financial impact.

Effects of New Accounting Pronouncements

                 Earnings Per Share. The Company adopted  Statement of Financial
Accounting Standard No. 128 ("SFAS 128"),  "Earnings Per Share" effective August
3, 1997. The effect of the adoption of SFAS 128 on the quarter and six


                                      -10-

<PAGE>

months ended  February 1, 1997 was to reduce the weighted  average common shares
and common share  equivalents  from 8,620,692 to 8,071,111 and from 8,561,147 to
8,082,482  for  the  three  and  six  month  periods  ended  February  1,  1997,
respectively. Diluted earnings per share were $.14 and $.26 as compared to fully
diluted  earnings per share of $.13 and $.25 for the three and six month periods
ended February 1, 1997, respectively.

                 Disclosures   About  Segments  of  an  Enterprise  and  Related
Information.  In June 1997,  the FASB issued SFAS No.  131,  "Disclosures  About
Segments of an Enterprise  and Related  Information."  SFAS No. 131 requires the
reporting of profit and loss, specific revenue and expense items, and assets for
reportable  segments.  It also  requires  the  reconciliation  of total  segment
revenues,  total segment profit and loss, total segment assets and other amounts
disclosed  for  segments to the  corresponding  amounts in the  general  purpose
financial  statements.  This  statement is effective  for  financial  statements
issued for periods  ending  after  December  15,  1997.  The Company has not yet
determined  what  additional  disclosures  may be  required in  connection  with
adopting SFAS No. 131.

                                      -11-

<PAGE>



                                     PART II

Item 1.        Legal Proceedings

                        None

Item 2.        Changes in Securities

                        None

Item 3.        Defaults on Senior Securities

                        None

Item 4.        Submission to a Vote of Security Holders

                        At the annual  meeting of  stockholders  of the  Company
                        held on February 10, 1998, the stockholders:

                        Elected the following directors: Natan V. Bertman, David
                        Michael,  Seymour  Rubin,  James  Tiernan and Leonard A.
                        Trugman.

                        Election of Directors     For      Withheld
                        ---------------------  ---------   --------

                        Leonard A. Trugman     6,330,252    127,680
                        Natan V. Bertman       6,327,736    130,196
                        David Michael          6,329,744    128,188
                        Seymour Rubin          6,325,912    132,020
                        James Tiernan          6,323,100    134,832

               (b)      Approved  the  amendment  to the  Company's  Amended and
                        Restated  Stock  Option Plan to  increase  the number of
                        shares reserved for issuance thereunder by 500,000.

                                                  For       Against    Abstain
                                               ---------    -------    -------

                                               2,999,682    981,877     57,054

               (c)      Approved the  appointment  of Deloitte & Touche,  LLP as
                        the Company's  independent  auditors for the fiscal year
                        ending August 1, 1998.

                                                  For       Against    Abstain
                                               ---------    -------    -------
 
                                               6,398,494     39,562     19,876

Item 5.        Other Information

                         None

Item 6.        Exhibits and Reports on Form 8-K
                            
               (a)      Exhibits:  Exhibit  11 -  Computation  of  Earnings  per
                        Common Share
                        Exhibit 27 - Financial Data Schedule

               (b)      Report on Form 8-K:  None

                                      -12-
<PAGE>
                                   SIGNATURES


        Pursuant to the requirements of the Securities and Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned, thereunto duly authorized.










                                                   DEL GLOBAL TECHNOLOGIES CORP.




                                                   /S/LEONARD A. TRUGMAN
                                                   ---------------------
                                                   Leonard A. Trugman
                                                   Chairman of the Board,
                                                   Chief Executive Officer
                                                   and President




                                                   /S/MICHAEL H. TABER
                                                   ---------------------
                                                   Michael H. Taber
                                                   Vice President - Finance,
                                                   Secretary and Chief
                                                   Accounting Officer



Dated:  March 13, 1998







                                      -13-